-7.
74. Wysocki AB, Staiano-Coico L, Grinnell F. Wound ﬂuid from chronic
leg ulcers contains elevated levels of metalloproteinases MMP-2 and
MMP-9. J Invest Dermatol 1993;101:64-8.
75. Weckroth M, Vaheri A, Lauharanta J, Sorsa T, Konttinen YT. Matrix
metalloproteinases, gelatinase and collagenase in chronic leg ulcers.
J Invest Dermatol 1996;106:1119-24.
76. Herouy Y, May AE, Pornschlegel G, Stetter C, Grenz H,
Preissner KT, et al. Lipodermatosclerosis is characterized by elevated
expression and activation of matrix metalloproteinases. Implications
for venous ulcer formation. J Invest Dermatol 1998;111:822-7.
77. Herouy Y, Trefzer D, Hellstern MO, Stark GB, Vanscheidt W,
Schöpf E, et al. Plasminogen activation in venous leg ulcers. Br J
Dermatol 2000;143:930-6.
78. Norgauer J, Hildenbrand T, Idzko M, Panther E, Bandemir E,
Hartmann M, et al. Elevated expression of extracellular matrix
metalloproteinase inducer (CD147) and membrane-type matrix
metalloproteinases in venous leg ulcers. Br J Dermatol 2002;147:
1180-6.
79. Mwaura B, Mahendran B, Hynes N, Defreitas D, Avalos G,
Adegbola T, et al. The impact of differential expression of extracellular

JOURNAL OF VASCULAR SURGERY
Volume 60, Number 2S

matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue
inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers. Eur J Vasc